Diversifying animal models: the use of hispid cotton rats (Sigmodon hispidus) in infectious diseases
about
sameAs
Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton ratsA nasal epithelial receptor for Staphylococcus aureus WTA governs adhesion to epithelial cells and modulates nasal colonizationInhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entryNitric oxide production and nitric oxide synthase type 2 expression by cotton rat (Sigmodon hispidus) macrophages reflect the same pattern as human macrophagesChinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus.Animal models for the study of leishmaniasis immunology.The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity.BCG vaccination in the cotton rat (Sigmodon hispidus) infected by the pulmonary route with virulent Mycobacterium tuberculosis.Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced ageBone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat modelEvaluation of cotton rats as a model for severe acute respiratory syndrome.A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanismBiological challenges and technological opportunities for respiratory syncytial virus vaccine development.The marmoset and cotton rat as animal models for the study of sperm chromatin packaging.Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV)Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptidesAnimal models of human respiratory syncytial virus diseaseImmunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus.Alternatives to retroorbital blood collection in hispid cotton rats (Sigmodon hispidus).Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.Acute and Chronic Airway Disease After Human Respiratory Syncytial Virus Infection in Cotton Rats (Sigmodon hispidus)Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirusA virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton ratsRespiratory virus infection in infants and children.Epithelial cell lines of the cotton rat (Sigmodon hispidus) are highly susceptible in vitro models to zoonotic Bunya-, Rhabdo-, and Flaviviruses.Pathogenesis and Chronologic Localization of the Human Influenza A (H1N1) Virus in Cotton Rats.Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.Animal models in virus research: their utility and limitations.Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus.Function and expression of CD1d and invariant natural killer T-cell receptor in the cotton rat (Sigmodon hispidus).Wall Teichoic Acid Glycosylation Governs Staphylococcus aureus Nasal Colonization.Methods for monitoring dynamics of pulmonary RSV replication by viral culture and by real-time reverse transcription-PCR in vivo: Detection of abortive viral replication.Nucleic acid-based vaccines targeting respiratory syncytial virus: delivering the goods.Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.Passive narcosis for anesthesia induction in cotton rats (Sigmodon hispidus).Mouse and Cotton Rat Models of Human Respiratory Syncytial Virus.The cotton rat model of respiratory viral infectionsEvaluation of Measles Vaccine Virus as a Vector to Deliver Respiratory Syncytial Virus Fusion Protein or Epstein-Barr Virus Glycoprotein gp350.The cotton rat (Sigmodon hispidus) as an animal model for respiratory tract infections with human pathogens.
P2860
Q30392931-D149ADCC-DB3F-4D2A-B53D-8D800E9D77E5Q33553796-396C15FC-24D8-423E-B623-58ACB68BE9C6Q33741962-559C7A91-76D7-4086-BFB2-8FC57C81D6AEQ33779306-9A2DB936-6F50-431B-AA91-BB3F4E2F03E6Q33780476-0A29DAF9-3FC7-4C12-B7CA-325B01861E76Q33859617-39384E63-3C99-4347-AE24-9A5EF51391CDQ33930308-02CF301B-AD81-40DD-BA04-CB144F2FEEABQ34020803-D212D432-23B3-4A92-9827-EFCB27FAD539Q34059447-116505B5-6290-45AE-A606-20E5013AE95EQ34183356-BF393CD1-650E-4DF4-8BBC-D6E117164328Q34296820-DB2393B6-5D05-4488-8D9E-C932F4427008Q34492100-B5ACBC6B-D7D6-4E67-BDF0-7562F798039BQ34504791-58500C41-4FC4-4737-97D6-9565F1690128Q34620417-6C0040FF-95D6-4549-8CE4-9B3FDC2252DCQ34881218-C0C5053A-EB5E-4063-A38A-0AE1D0B7FBB6Q34991022-45512D7A-333F-49C1-9C6F-71A3F9368BA1Q35159747-6694552C-4C53-4468-85EC-F02AB36CE0EEQ35625850-7D8C02F9-3708-4805-9B2C-3827D0419AFAQ35858315-B7F6CFAF-7A7B-4A84-86B0-75294A7284CCQ35973436-C4E693F3-77BF-4404-B84F-EBDF7699CBC5Q35996472-B3A474C8-24B8-4ED0-BDB0-887FEFAB4C82Q36080869-084F162E-EAEB-4DB2-B99E-A18463379161Q36184357-48F3CD33-99B3-4FA1-90AF-08EC4F595ADEQ36251566-9020A818-4050-4B8E-9958-A3F32A40AD6BQ36834315-6475C7D4-78DF-4959-AF1B-6C67B9CF5726Q36866624-24F5408F-EFA5-44C0-8820-832D125422DCQ37155692-12AEDDF0-E36D-4C06-B5D0-A5BFE62894E6Q37320191-899AFD3C-F080-4514-ABB6-B1DC90DC2FE7Q38043556-FB18A08E-65FD-45FC-A986-1DA2253ED427Q38835118-6E93BFFF-26E8-4602-B1D8-BA0508CF23F1Q38837176-7A5B54B6-F69C-46BB-9D64-AEA7CF44F2ECQ38989590-6561B447-23E2-405B-B93F-F56EB45A3379Q39726748-B9FDE6A6-4ECE-4095-8E38-6C9F7B76A90FQ40053603-0FFCEB4D-0A75-48FD-9885-3E80D4464775Q40355982-30A62E8C-1AAD-4788-8E03-2933AF14BD09Q40566416-95E11C44-55E7-4C8C-8F19-50784B691374Q40597742-256D1493-DA0F-4A65-B609-82F2190FA65DQ40945079-CB93C501-F123-4A77-9496-66F0A1A683E6Q41557807-B684166A-E742-4A85-97AE-F61DB6BD3602Q43788138-2E58687E-578F-4F1A-843B-CBE8A4CF6669
P2860
Diversifying animal models: the use of hispid cotton rats (Sigmodon hispidus) in infectious diseases
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Diversifying animal models: th ...... spidus) in infectious diseases
@ast
Diversifying animal models: th ...... spidus) in infectious diseases
@en
Diversifying animal models: th ...... spidus) in infectious diseases
@nl
type
label
Diversifying animal models: th ...... spidus) in infectious diseases
@ast
Diversifying animal models: th ...... spidus) in infectious diseases
@en
Diversifying animal models: th ...... spidus) in infectious diseases
@nl
prefLabel
Diversifying animal models: th ...... spidus) in infectious diseases
@ast
Diversifying animal models: th ...... spidus) in infectious diseases
@en
Diversifying animal models: th ...... spidus) in infectious diseases
@nl
P3181
P1433
P1476
Diversifying animal models: th ...... spidus) in infectious diseases
@en
P2093
Gregory Prince
Stefan Niewiesk
P304
P3181
P356
10.1258/002367702320389026
P407
P577
2002-10-01T00:00:00Z